olmesartan medoxomil has been researched along with Cough in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koike, H; Nussberger, J | 1 |
1 review(s) available for olmesartan medoxomil and Cough
| Article | Year |
|---|---|
Antagonizing the angiotensin II subtype 1 receptor: a focus on olmesartan medoxomil.
Topics: Angioedema; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Clinical Trials as Topic; Cough; Humans; Imidazoles; Olmesartan Medoxomil; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles | 2004 |